This opportunity is supported by the partnership between WEHI and The Australian Alliance for Indigenous Genomics (ALIGN). ALIGN is a purposeful alliance between community, health, research, government, and industry that privileges Indigenous leadership and sovereignty. ALIGN aims to deliver equity and benefit to Indigenous Australians through genomics. ALIGN seeks to synergistically build and extend Indigenous leadership and involvement in genomic science, research, precision health care, data sciences, ethics and Indigenous knowledge systems to reduce health inequality among Australia’s First Peoples. This opportunity with WEHI is one initiative to support Indigenous leadership and involvement in genomic science and research.
The Immunogenomics Lab investigates the mechanisms of human immune health and disease by exploring how variations in gene expression and immune cell programming influence immune function. Using functional immunology, clinical genomics, and high-resolution single cell omics, we aim to develop new diagnostic tools and identify therapeutic targets that bridge the gaps between clinical genomics, immune cell function, and precision care. Our research focuses on rare immune disorders, with a particular emphasis on Common Variable Immunodeficiency (CVID), both as a primary immunodeficiency and as a model for understanding broader immune dysfunction.
We are committed to translating our research discoveries into clinical impact. We lead key national initiatives, including the ALIGN Immunogenomics Flagship Program and the Australian Immunogenomics Alliance, MRFF-funded programs dedicated to improving diagnostic rates and ensuring equitable access to genomic testing for people with rare and complex immune diseases. As part of the Snow Centre for Immune Health, Dr Bryant and Dr Slade serves as Co-Deputy Directors, working to advance research and clinical translation for complex immune disorders.
This project is part of the Indigenous Visiting Research Fellowships, for full details please visit the link below.